more

Client Profile

SironRX Therapeutics

SironRX is developing novel therapies exclusively licensed from Juventas Therapeutics and Cleveland Clinic that promote wound repair and prevent scarring of dermal wounds.  Our lead product, SRX-100 is a clinically tested product that encodes Stromal cell-Derived Factor-1 (SDF-1).  SDF-1 is produced by the body in response to tissue injury and activates natural repair processes to prevent cell death and recruit stem cells to the damaged organ.